Navigation Links
Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
Date:9/14/2009

n migraine studies is the percentage of patients who are pain-free at 2 hours post-dose. Again, AZ-104 was numerically superior to placebo in this measure, but the differences were not statistically significant. Pain-free responders were 31% of the patients receiving the 2.5 mg dose and 27% of the patients receiving the 1.25 mg dose, as compared to 23% of the patients receiving placebo.

Conference Call Information

Alexza will host a conference call today, Monday, September 14, 2009 at 9:00 a.m. Eastern Time. A replay of the call will be available for two weeks following the event. The conference call and replay are open to all interested parties.

To access the conference call via the Internet, go to www.alexza.com, under the "Investor Relations" link. Please join the call at least 15 minutes prior to the start of the call to ensure time for any software downloads that may be required. Interested parties may also pre-register to avoid pre-call delays athttps://www.theconferencingservice.com/prereg/key.process?key=PVQ6TNNCG.

To access the live conference call via phone, dial 888-680-0860. International callers may access the live call by dialing 617-213-4852. The reference number to enter the call is 93505561.

The replay of the conference call may be accessed via the Internet, at www.alexza.com, or via phone at 888-286-8010 for domestic callers or 617-801-6888 for international callers. The reference number for the replay of the call is 16727234.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Calif. , May 21, 2013 RenovoRx ... prestigious 2013 TiE50 "Top Startup" Award at TiEcon 2013, ... innovation, strong management team and quality of entrepreneurial ideas. ... at the Santa Clara Convention ... highly influential list of the most enterprising startup companies ...
(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... image and impressive new product developments at the Special Libraries ... ten years of unerring focus on product literature databases and ... to mark the occasion," said founding director Nigel ... interesting developments of benefit to our clients and what better ...
(Date:5/21/2013)... , May 21, 2013 /PRNewswire-iReach/ -- The 2013 ... NJ has attracted the greatest number of "Emerging" ... President, Mark Alexay .  "No ... to attend this year.  The show,s still 4 months ... companies.  This is a big surprise and great ...
Breaking Medicine Technology:RenovoRx Named Winner of 2013 TiE50 "Top Startup" 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2
... Conn., Jan. 7 Alexion,Pharmaceuticals, Inc. (the ... commenced dosing in the AEGIS study, a ... and pharmacology of Soliris(R) (eculizumab),as a treatment ... When fully enrolled, the open-label study, authorized,by ...
... Innocoll, Inc., a privately-held,specialty pharmaceutical company, announced ... phase 2 clinical trials sponsored by its ... CollaRx(R) BUPIVACAINE SURGICAL,IMPLANT for the management of ... BUPIVACAINE SURGICAL IMPLANT is a biodegradable and ...
Cached Medicine Technology:Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 2Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 3Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 4Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 5Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan 6Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain 4
(Date:5/21/2013)... on a large scale is the cornerstone of ... better outcomes, better value and better experience of ... patient-centered medical home model offers a viable solution ... of Health and Human Services, Agency for Healthcare ... more about the processes and determinants of successful ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 HealthSmart continues ... expanding national presence has required the hiring of new ... HealthSmart is pleased to announce that Dawn Powell has ... serving as the Director of Account Management in the ... offices in Irving, Texas. With extensive client management, employee ...
(Date:5/21/2013)... According to a May 13, 2013 New Zealand ... Botox injections have become the most popular cosmetic ... to goo.gl/8iYbD). Although it is mostly associated with women, ... makes facial wrinkles less visible by paralyzing facial muscles. The ... months. This means that people who are conscious about their ...
(Date:5/21/2013)... Los Angeles, CA (PRWEB) May 21, 2013 ... combat sports organization, and Bodybuilding.com, the largest online retailer ... bring you a new reality-based sports show, Warrior Island. ... fans vote on; YouTube, Facebook & Twitter, with our ... Warrior Island maroons these elite fighters on an ...
(Date:5/21/2013)... Research into genetic features of pulmonary fibrosis by physicians ... Medicine may lead to improved treatment of this deadly ... JAMA . , The study found that a ... of pulmonary fibrosis, a chronic progressive disease with a ... the study, researchers may want to consider including genetic ...
Breaking Medicine News(10 mins):Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2
... TORONTOA large group of soldiers returning from Iraq ... the small airways of the lung, according to ... their findings at the American Thoracic Societys 2008 ... A total of 56 soldiers from Fort Campbell, ...
... 21 The warm weather provides the,perfect opportunity ... and confidence,with a plan that combines smarter eating ... http://www.newscom.com/cgi-bin/prnh/20080415/NYTUFNS1 ), "The key to controlling ... activity," said Peggy Fleming, Olympic figure skating,champion and ...
... Program Provides Continuing CKD Nutrition Education for Non-Renal ... ... a leading,provider of kidney care services for those diagnosed with chronic ... (Expand Your Expertise in CKD Nutrition) workshop on March 6,2008 in ...
... SHANGHAI, China, May 21 /Xinhua-PRNewswire/ -- WuXi ... medical device research,and development outsourcing company with ... proud to announce that the distinguished Stanford ... ) has,visited WuXi PharmaTech and given ...
... N.Y., May 21 Babies born,preterm were more than ... infants, according to a new analysis of nearly 7 ... Springer journal Maternal and,Child Health Journal., Preterm birth, ... national health crisis, according to the March of Dimes. ...
... WASHINGTON, May 20 Accelerate Brain Cancer,Cure ... its,website from leading brain cancer specialists covering important ... as valuable guidance for newly,diagnosed brain cancer patients., ... with some of the worlds,leading researchers in the ...
Cached Medicine News:Health News:Iraq war service: A risk factor for bronchiolitis? 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 5Health News:DaVita Renal Dietitians Conduct First-Ever 'EYE on CKD' Workshop 2Health News:Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars 2Health News:Analysis of Millions of U.S. Births Shows Association Between Birth Defects and Preterm Birth 2Health News:Brain Cancer Science and Treatment Information 2
The TBR-360-1-GD is a large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standar...
... is specially designed for ... in standard 500ml bags, ... AS3864 1997. Quiet hermetic ... CFC Free refrigerant with ...
... a direct competitive EIA for the ... serum or plasma. A specific agent ... it available for antibody binding. Testosterone ... linked to fluorescein isothiocyanate (FITC) and ...
... Vitamin B6 makes it possible to determine ... precise method. The kits includes all reagents ... separation of the samples with,exception of the ... the simultaneous handling of many analytes in ...
Medicine Products: